Trials / Completed

CompletedNCT01184495

Efficacy Study of Two Formulations of Erythropoietin

Comparison of the Efficacy of Erythropoietin Produced in the Institute of Technology in Immunobiology of the Oswald Cruz Foundation (BioMaguinhos/FioCruz/MS) and Erythropoietin Industrialized in Patients With Chronic Renal Failure

Status: Completed
Phase: Phase 3
Study type: Interventional
Enrollment: 74 (actual)

Sponsor: Hospital de Clinicas de Porto Alegre · Academic / Other
Sex: All
Age: 18 Years
Healthy volunteers: Not accepted

Summary

A double-blind, randomized trial aimed to compare the efficacy of two formulations of erythropoietin in patients with chronic renal failure on hemodialysis

Conditions

Comparison of the Efficacy of Two Formulations of Epoetin in Patients Undergoing Hemodialysis

Interventions

Type	Name	Description
DRUG	Epoetin Alfa-BioManguinhos	Subcutaneous administration of EPO-BioManguinhos
DRUG	Epoetin Alfa-BioSimilar	Subcutaneous administration of EPO-BioSimilar

Timeline

Start date: 2008-04-01
Primary completion: 2008-12-01
Completion: 2009-01-01
First posted: 2010-08-19
Last updated: 2017-02-27

Source: ClinicalTrials.gov record NCT01184495. Inclusion in this directory is not an endorsement.